SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001395064-23-000040
Filing Date
2023-05-26
Accepted
2023-05-26 07:08:15
Documents
1
Period of Report
2023-04-17

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_168509928424875.html 4  
1 FORM 4 wf-form4_168509928424875.xml 4 7949
  Complete submission text file 0001395064-23-000040.txt   10025
Mailing Address 1-1, NIHONBASHI-HONCHO 2-CHOME, CHUO-KU TOKYO M0 103-8668
Business Address 1-1, NIHONBASHI-HONCHO 2-CHOME, CHUO-KU TOKYO M0 103-8668 81332782111
TAKEDA PHARMACEUTICAL CO LTD (Reporting) CIK: 0001395064 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36644 | Film No.: 23963025
SIC: 2834 Pharmaceutical Preparations

Mailing Address 343 OYSTER POINT BLVD #200 SOUTH SAN FRANCISCO CA 94080
Business Address 343 OYSTER POINT BLVD #200 SOUTH SAN FRANCISCO CA 94080 650-870-1000
Calithera Biosciences, Inc. (Issuer) CIK: 0001496671 (see all company filings)

IRS No.: 272366329 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 9625 TOWNE CENTRE DRIVE SAN DIEGO CA 92121
Business Address 9625 TOWNE CENTRE DRIVE SAN DIEGO CA 92121 619-930-8101
Takeda Ventures, Inc. (Reporting) CIK: 0001771657 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36644 | Film No.: 23963024